84 related articles for article (PubMed ID: 16489326)
1. A case of ulcerative jejunoileitis treated with anti tumor necrosis factor-alpha antibodies.
Gaia S; Bruno M; Marzano A; Novero D; Astegiano M; Actis GC; Rizzetto M
Panminerva Med; 2005 Dec; 47(4):269-72. PubMed ID: 16489326
[No Abstract] [Full Text] [Related]
2. Use of anti tumor necrosis factor-alpha monoclonal antibody for ulcerative jejunoileitis.
Seven G; Assaad A; Biehl T; Kozarek RA
World J Gastroenterol; 2012 Sep; 18(36):5135-7. PubMed ID: 23049226
[TBL] [Abstract][Full Text] [Related]
3. [Collagenous sprue and ulcerative jejuno-ileitis in a patient with gluten-induced enteropathy].
Güller R; Anabitarte M; Mayer M
Schweiz Med Wochenschr; 1986 Sep; 116(39):1343-9. PubMed ID: 3775341
[TBL] [Abstract][Full Text] [Related]
4. Nongranulomatous ulcerative jejunoileitis.
Freeman M; Cho SR
Am J Gastroenterol; 1984 Jun; 79(6):446-9. PubMed ID: 6731417
[TBL] [Abstract][Full Text] [Related]
5. Use of azathioprine for nongranulomatous ulcerative jejunoileitis.
Enns R; Lay T; Bridges R
Can J Gastroenterol; 1997 Sep; 11(6):503-6. PubMed ID: 9347165
[TBL] [Abstract][Full Text] [Related]
6. Literature review on the clinical relationship between ulcerative jejunoileitis, coeliac disease, and enteropathy-associated T-cell.
Biagi F; Lorenzini P; Corazza GR
Scand J Gastroenterol; 2000 Aug; 35(8):785-90. PubMed ID: 10994614
[No Abstract] [Full Text] [Related]
7. [Celiac disease, dermatitis herpetiformis and erosive jejunoileitis].
Eugène C; Fingerhut A; Bergue A; Bergal S; Gerbal JL; Quevauvilliers J
Gastroenterol Clin Biol; 1983 Oct; 7(10):812-7. PubMed ID: 6628914
[TBL] [Abstract][Full Text] [Related]
8. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
9. Colonic volvulus and ulcerative jejunoileitis due to occult celiac sprue.
Riobó P; Turbí C; Banet R; Badia A; Lara JI; Miranda R; Herrera-Pombo JL
Am J Med Sci; 1998 May; 315(5):317-8. PubMed ID: 9587089
[TBL] [Abstract][Full Text] [Related]
10. Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody.
Dini V; Romanelli M; Bertone M; Talarico S; Bombardieri S; Barachini P
Int J Low Extrem Wounds; 2007 Jun; 6(2):108-13. PubMed ID: 17558009
[TBL] [Abstract][Full Text] [Related]
11. Differential response of psoriatic onycho-pachydermo-periostitis to 2 anti-tumor necrosis factor-alpha agents.
Kapusta MA; Dumont C
J Rheumatol; 2008 Oct; 35(10):2077-80. PubMed ID: 18843767
[No Abstract] [Full Text] [Related]
12. Ulcerative jejunoileitis: a complication of celiac sprue simulating Crohn's disease diagnosed with capsule endoscopy (PillCam).
LePane CA; Barkin JS; Parra J; Simon T
Dig Dis Sci; 2007 Mar; 52(3):698-701. PubMed ID: 17268829
[No Abstract] [Full Text] [Related]
13. Ulcerative jejunoileitis and enteropathy-associated T-cell lymphoma.
Elsing C; Placke J; Gross-Weege W
Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1401-5. PubMed ID: 16292096
[TBL] [Abstract][Full Text] [Related]
14. Refractory Takayasu arteritis successfully treated with infliximab.
Maffei S; Di Renzo M; Santoro S; Puccetti L; Pasqui AL
Eur Rev Med Pharmacol Sci; 2009; 13(1):63-5. PubMed ID: 19364087
[TBL] [Abstract][Full Text] [Related]
15. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.
Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Suzuki K; Tanaka Y
Rheumatology (Oxford); 2009 Aug; 48(8):1012-3. PubMed ID: 19465589
[No Abstract] [Full Text] [Related]
16. Association between the level of circulating bioactive tumor necrosis factor alpha and the tumor necrosis factor alpha gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor alpha inhibitor.
Marotte H; Arnaud B; Diasparra J; Zrioual S; Miossec P
Arthritis Rheum; 2008 May; 58(5):1258-63. PubMed ID: 18438841
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumour necrosis factor alpha therapy modulates ghrelin in patients with severe rheumatoid arthritis.
Gonzalez-Gay MA; Garcia-Unzueta MT; Berja A; Vazquez-Rodriguez TR; Gonzalez-Juanatey C; de Matias JM; Martin J; Dessein PH; Llorca J
Ann Rheum Dis; 2008 Nov; 67(11):1644-6. PubMed ID: 18854515
[No Abstract] [Full Text] [Related]
19. Anti-tumour necrosis factor agents and lipid profile: a class effect?
Garcês SP; Parreira Santos MJ; Vinagre FM; Roque RM; da Silva JA
Ann Rheum Dis; 2008 Jun; 67(6):895-6. PubMed ID: 18474660
[No Abstract] [Full Text] [Related]
20. Treatment of Takayasu's arteritis with tumor necrosis factor antagonists.
Filocamo G; Buoncompagni A; Viola S; Loy A; Malattia C; Ravelli A; Martini A
J Pediatr; 2008 Sep; 153(3):432-4. PubMed ID: 18718263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
